BLTE FY 2024 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena

BLTEBelite Bio, Inc

$7B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$40M

Net Income

-$36M

EPS (Diluted)

$-1.18

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$152M

Total Liabilities

$6M

Stockholders' Equity

$146M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$40M	-$32M	-26.3%
Net Income	-$36M	-$32M	-14.3%